Objective: To evaluate the long-term outcome in a cohort of patients with primary SS (PSS) using the recently proposed Sjogren's Syndrome Damage Index. Methods: We reviewed the clinical records of 60 patients attending our Sjögren's clinic at University College London Hospital, who strictly fulfilled the American-European Consensus Group criteria and on whom we had a minimum of 10 years of follow-up (or until death) during this decade. However, we could not retrospectively identify damage in the oral domain as this had not been recorded reliably. Results: Fifty-five per cent of patients in this study had no damage after 10 years of disease-a lower figure than our comparative group of patients with SLE (32.4%). Damage accrual was mostly in the ocular domain, parotid swelling and malignancy categories. There was a 6-fold increase in the 'malignancy damage' compared with the 2-fold increase in the total damage score in PSS. Conclusions: Unlike patients with SLE, it is clear that fewer patients with SS develop permanent damage, even after 10 years of follow-up. These data are thus encouraging but clearly larger numbers of patients need to be assessed. © The Author 2010.
CITATION STYLE
Krylova, L., & Isenberg, D. (2010). Assessment of patients with primary Sjögren’s syndrome-outcome over 10 years using the Sjögren’s Syndrome Damage Index. Rheumatology, 49(8), 1559–1562. https://doi.org/10.1093/rheumatology/keq086
Mendeley helps you to discover research relevant for your work.